 |
 |
 |
 |
 |
|
|
 Ophena™ |
| Fispemifene |
 |
 |
QuatRx's clinical pipeline includes two compounds in clinical development.
Learn more about the QuatRx Clinical Portfolio by exploring Ophena™ and Fispemifene.
|
Terms of Use|
|
|
|
||||||||||
|
||||||||||||
|
|
||||||||||||
|
|
QuatRx's clinical pipeline includes two compounds in clinical development.
Learn more about the QuatRx Clinical Portfolio by exploring Ophena™ and Fispemifene. |
||||||||||
|
|
||||||||||||
|
|
||||||||||||
|
|
|||||||||||
|
|
||||||||||||
| © 2011 QuatRx Pharmaceuticals CompanyTerms of Use |
|
|||||||||||
|
|
|
|
|
|
|
|
||||||